Introduction
Calquence 100mg Capsule:

Calquence
100mg Capsule is an anticancer medicine containing the active constituent
Acalabrutinib. It belongs to a class of drugs called Bruton's tyrosine kinase
(BTK) inhibitors. It is used to treat mantle cell lymphoma (MCL), chronic
lymphocytic leukaemia (CLL), and small lymphocytic lymphoma (SLL). MCL, CLL,
and SLL are cancers of the white blood cells called lymphocytes that are part
of the immune system. They differ from each other by the location where cancer
occurs and the type of lymphocytes affected.

Before
taking this medicine, inform your doctor if you have had recent surgery,
bleeding problems, heart rhythm problems, infection, pregnancy, or
breastfeeding. It is not recommended for children and adolescents less than 18
years old. This medicine can increase the risk of bleeding. Patients taking
Calquence 100mg Capsule should be monitored for signs of bleeding and should
avoid taking other medications that can increase the risk of bleeding, such as
blood thinners.

Uses of Calquence 100mg
Capsule:

• Chronic lymphocytic leukemia
• Small lymphocytic lymphoma
• Mantle cell lymphoma

How
to consume Calquence 100mg Capsule:

Calquence 100mg Capsule is typically taken
orally, with or without food. The tablets should be swallowed whole, not
crushed, chewed, or broken. The recommended dosage can vary depending on the
type of cancer being treated and other factors such as your overall health and
response to treatment. Do not take a double dose to make up for a missed dose.